GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (OTCPK:SFOSF) » Definitions » Purchase Of Property, Plant, Equipment

SFOSF (Shanghai Fosun Pharmaceutical (Group) Co) Purchase Of Property, Plant, Equipment : $-612 Mil (TTM As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Purchase Of Property, Plant, Equipment?

Shanghai Fosun Pharmaceutical (Group) Co's purchase of property, plant, equipment for the three months ended in Dec. 2024 was $-190 Mil. It means Shanghai Fosun Pharmaceutical (Group) Co spent $190 Mil on purchasing property, plant, equipment. Shanghai Fosun Pharmaceutical (Group) Co's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2024 was $-612Mil.

Compared with last quarter ($-132 Mil in Sep. 2024 ), Shanghai Fosun Pharmaceutical (Group) Co spent more money on purchasing property, plant, equipment in Dec. 2024 ($-190 Mil).


Shanghai Fosun Pharmaceutical (Group) Co Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Purchase Of Property, Plant, Equipment Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Property, Plant, Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -678.53 -780.75 -844.68 -747.42 -605.74

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Purchase Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -156.75 -174.19 -115.64 -131.94 -189.99

Shanghai Fosun Pharmaceutical (Group) Co Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-612 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Fosun Pharmaceutical (Group) Co Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Fosun Pharmaceutical (Group) Co Business Description

Traded in Other Exchanges
Address
No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.